10.73
+0.2(+1.90%)
Currency In USD
| Previous Close | 10.53 |
| Open | 10.56 |
| Day High | 10.89 |
| Day Low | 10.53 |
| 52-Week High | 15.72 |
| 52-Week Low | 9.2 |
| Volume | 970,649 |
| Average Volume | 761,475 |
| Market Cap | 635.43M |
| PE | 4.55 |
| EPS | 2.36 |
| Moving Average 50 Days | 11.56 |
| Moving Average 200 Days | 12.27 |
| Change | 0.2 |
If you invested $1000 in Embecta Corp. (EMBC) since IPO date, it would be worth $246.67 as of February 21, 2026 at a share price of $10.73. Whereas If you bought $1000 worth of Embecta Corp. (EMBC) shares 3 years ago, it would be worth $367.59 as of February 21, 2026 at a share price of $10.73.
For more details, use our stock calculator to calculate how much you would've made investing different amounts on specific dates.
embecta names new Chairman of the Board and Lead Independent Director
GlobeNewswire Inc.
Feb 11, 2026 9:10 PM GMT
PARSIPPANY, N.J., Feb. 11, 2026 (GLOBE NEWSWIRE) -- Embecta Corp. (“embecta”) (Nasdaq: EMBC), a global company that is advancing its 100-year legacy in insulin delivery to become a broad-based medical supplies company, today announced that the Boar
Embecta Corp. Reports First Quarter Fiscal 2026 Financial Results
GlobeNewswire Inc.
Feb 05, 2026 11:30 AM GMT
PARSIPPANY, N.J., Feb. 05, 2026 (GLOBE NEWSWIRE) -- Embecta Corp. (“embecta”) (Nasdaq: EMBC), a global company that is advancing its 100-year legacy in insulin delivery to become a broad-based medical supplies company, today reported first quarter
embecta to Report Fiscal First Quarter Financial Results
GlobeNewswire Inc.
Jan 22, 2026 10:00 PM GMT
PARSIPPANY, N.J., Jan. 22, 2026 (GLOBE NEWSWIRE) -- Embecta Corp. (“embecta”) (Nasdaq: EMBC), a global company that is advancing its 100-year legacy in insulin delivery to become a broad-based medical supplies company, will host a conference call t